Market Overview:
The global calcitonin (salmon) market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of osteoporosis, increasing geriatric population and growing demand for minimally invasive procedures. Based on type, the global calcitonin (salmon) market is segmented into spray and injection. Injection held a dominant share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to benefits such as ease of use and accuracy offered by injections over sprays. However, spray held a higher growth rate than injection during the forecast period owing to increasing preference for convenience over other factors among consumers globally. Based on application, hospitals accounted for majority share in 2017 and is projected to maintain its dominance throughout the forecast period due high prevalence of osteoporosis cases coupled with rising number of minimally invasive procedures being performed in this sector globally .
Product Definition:
A hormone secreted by the thyroid gland in response to low blood calcium levels. It increases calcium absorption from the intestine and promotes deposition of calcium in bone.
Spray:
Spray is a device used to administer drugs. It’s an aerosol-generating machine that sprays the drug into the air where it falls on the target area and enters through the nose and mouth. The drug is mixed with inert gases such as nitrogen, oxygen, carbon dioxide or other gases which are present in different ratios for specific needs.
The spray acts faster than oral medications because it bypasses first pass metabolism in liver.
Injection:
Injection is a process through which the active ingredients of the pharmaceutical are introduced into the dosage form by means of an injectable drug delivery system. The most commonly used injectable drug delivery systems are syringes, vials, and cartridges.
The global injection market is expected to grow at a lucrative rate over the forecast period owing to increasing incidences of diseases such as arthritis, osteoporosis.
Application Insights:
The market is segmented into hospitals, clinics and others. The hospitals segment dominated the global market in 2017 owing to factors such as increasing awareness about the benefits of calcitonin for patients suffering from heart diseases and growing spending power of consumers in developed economies such as U.S., Germany, Japan and France.
The clinics application segment is expected to witness lucrative growth over the forecast period due to rising demand for natural healing therapies that do not involve any harmful side effects or drug interactions. Furthermore, rising consumer preference towards minimally invasive procedures that offer faster results is anticipated to boost product demand in this application segment over the forecast period.
Regional Analysis:
North America dominated the global market in 2017 owing to high awareness levels regarding diseases and their treatment, presence of well-established healthcare facilities, and availability of advanced medicines. Moreover, increasing prevalence of osteoporosis due to increased age is expected to fuel demand for calcitonin in North America over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising geriatric population prone to osteoporosis coupled with improving economic conditions leading towards better healthcare facilities & infrastructure development. Furthermore, increasing number of R&D activities by various companies will also boost regional market growth during the forecast period. For instance; In April 2016; Novo Nordisk A/S.
Growth Factors:
- Increasing prevalence of osteoporosis and other bone disorders: The global calcitonin (salmon) market is expected to benefit from the increasing prevalence of osteoporosis and other bone disorders. This is primarily owing to the therapeutic benefits of calcitonin (salmon) in treating these conditions.
- Growing geriatric population: The global geriatric population is growing at a rapid pace, which is expected to drive the demand for calcitonin (salmon) products over the forecast period. Elderly people are more susceptible to developing bone-related disorders, thus increasing the demand for therapies such as calcitonin (salmon).
- Rising awareness about osteoporosis and its treatment options: There has been a rise in awareness about osteoporosis in recent years, which is likely to boost demand for calcitonin (salmon) products over the forecast period. This can be attributed to initiatives by various healthcare organizations aimed at raising awareness about this disorder and its treatment options.
- Technological advancements in salmon production: The technological advancements being made in salmon production are likely to benefit the growth of the global calcitonin (salmon) market over the forecast period. These advancements have led to an increase in production capacity, thereby resulting in lower product prices and making it more affordable for consumers worldwide.. 5 Increased focus on research & development activities: Pharmaceutical companies are increasingly focusing on research & development activities with regards to new
Scope Of The Report
Report Attributes
Report Details
Report Title
Calcitonin (salmon) Market Research Report
By Type
Spray, Injection
By Application
Hospitals, Clinics
By Companies
Novartis, Abcam, Sanofi Aventis, Mylan Pharmaceuticals, Sebela Pharmaceuticals, Sandoz, Ferring Pharmaceuticals, Apotex Corporation, Par Pharmaceutical, Upsher Smith Laboratories, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
127
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global Calcitonin (salmon) Market Report Segments:
The global Calcitonin (salmon) market is segmented on the basis of:
Types
Spray, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Abcam
- Sanofi Aventis
- Mylan Pharmaceuticals
- Sebela Pharmaceuticals
- Sandoz
- Ferring Pharmaceuticals
- Apotex Corporation
- Par Pharmaceutical
- Upsher Smith Laboratories
- Novartis
Highlights of The Calcitonin (salmon) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spray
- Injection
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Calcitonin (salmon) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Calcitonin is a hormone produced by the parathyroid glands in response to elevated levels of calcium in the blood. It helps to reduce inflammation and promote healing.
Some of the key players operating in the calcitonin (salmon) market are Novartis, Abcam, Sanofi Aventis, Mylan Pharmaceuticals, Sebela Pharmaceuticals, Sandoz, Ferring Pharmaceuticals, Apotex Corporation, Par Pharmaceutical, Upsher Smith Laboratories, Novartis.
The calcitonin (salmon) market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Calcitonin (salmon) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Calcitonin (salmon) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Calcitonin (salmon) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Calcitonin (salmon) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Calcitonin (salmon) Market Size & Forecast, 2018-2028 4.5.1 Calcitonin (salmon) Market Size and Y-o-Y Growth 4.5.2 Calcitonin (salmon) Market Absolute $ Opportunity
Chapter 5 Global Calcitonin (salmon) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Calcitonin (salmon) Market Size Forecast by Type
5.2.1 Spray
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Calcitonin (salmon) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Calcitonin (salmon) Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Calcitonin (salmon) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Calcitonin (salmon) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Calcitonin (salmon) Analysis and Forecast
9.1 Introduction
9.2 North America Calcitonin (salmon) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Calcitonin (salmon) Market Size Forecast by Type
9.6.1 Spray
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Calcitonin (salmon) Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Calcitonin (salmon) Analysis and Forecast
10.1 Introduction
10.2 Europe Calcitonin (salmon) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Calcitonin (salmon) Market Size Forecast by Type
10.6.1 Spray
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Calcitonin (salmon) Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Calcitonin (salmon) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Calcitonin (salmon) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Calcitonin (salmon) Market Size Forecast by Type
11.6.1 Spray
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Calcitonin (salmon) Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Calcitonin (salmon) Analysis and Forecast
12.1 Introduction
12.2 Latin America Calcitonin (salmon) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Calcitonin (salmon) Market Size Forecast by Type
12.6.1 Spray
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Calcitonin (salmon) Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Calcitonin (salmon) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Calcitonin (salmon) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Calcitonin (salmon) Market Size Forecast by Type
13.6.1 Spray
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Calcitonin (salmon) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Calcitonin (salmon) Market: Competitive Dashboard
14.2 Global Calcitonin (salmon) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Abcam
14.3.3 Sanofi Aventis
14.3.4 Mylan Pharmaceuticals
14.3.5 Sebela Pharmaceuticals
14.3.6 Sandoz
14.3.7 Ferring Pharmaceuticals
14.3.8 Apotex Corporation
14.3.9 Par Pharmaceutical
14.3.10 Upsher Smith Laboratories
14.3.11 Novartis